Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...

The Prostate Cancer Foundation (PCF) is proud to announce the launch of an interactive website and downloadable guide, Somatic and Germline Genetic Testing for Patients with Advanced Prostate ...

Prostate cancer is one of the most common and deadly forms of cancer in men, yet early detection remains a major challenge. That difficulty lies in how subtle the disease can be in its earliest stages ...

The Urology Care Foundation and the Prostate Cancer Foundation have created a new educational guide on genetic tests to guide ...

Prostate is one of the most commonly diagnosed cancers among men, particularly with advancing age. According to Dr Ahmed ...

INDIANAPOLIS (WISH) — Prostate cancer remains a significant health concern, being the second leading cause of death among men, particularly affecting black men. Early detection of prostate cancer is ...

Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit ...

A silent killer that is the second leading cause of death among American men, prostate cancer is a disease that has recently come to the forefront of medical research. Studies and new reviews are ...

Prostate cancer is the most common cancer in men, with about 1-in-8 expected to be diagnosed in their lifetime.